11-5233097-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000519.4(HBD):c.316-5C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,613,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000519.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBD | NM_000519.4 | c.316-5C>T | splice_region_variant, intron_variant | ENST00000650601.1 | NP_000510.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBD | ENST00000650601.1 | c.316-5C>T | splice_region_variant, intron_variant | NM_000519.4 | ENSP00000497529.1 | |||||
HBD | ENST00000643122.1 | c.316-5C>T | splice_region_variant, intron_variant | ENSP00000494708.1 | ||||||
HBD | ENST00000292901.7 | c.316-299C>T | intron_variant | 3 | ENSP00000292901.3 | |||||
HBD | ENST00000417377.1 | c.93-5C>T | splice_region_variant, intron_variant | 3 | ENSP00000414741.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152074Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251024Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135688
GnomAD4 exome AF: 0.000148 AC: 216AN: 1461606Hom.: 0 Cov.: 32 AF XY: 0.000154 AC XY: 112AN XY: 727126
GnomAD4 genome AF: 0.000197 AC: 30AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74288
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jan 05, 2021 | - - |
HBD-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at